Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $675.00 at JPMorgan Chase & Co.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective lifted by research analysts at JPMorgan Chase & Co. from $575.00 to $675.00 in a research note issued on Friday,Benzinga reports. The firm currently has an "overweight" rating on the medical equipment provider's stock. JPMorgan Chase & Co.'s price target points to a potential upside of 16.00% from the company's current price.

A number of other brokerages have also issued reports on ISRG. Piper Sandler reissued an "overweight" rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a report on Thursday, October 17th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Raymond James lifted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a report on Monday, October 14th. Finally, Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $583.83.

Intuitive Surgical Trading Down 4.4 %

Shares of NASDAQ:ISRG traded down $26.75 during trading on Friday, reaching $581.91. 3,080,909 shares of the company traded hands, compared to its average volume of 1,909,580. Intuitive Surgical has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $207.27 billion, a price-to-earnings ratio of 93.62, a P/E/G ratio of 5.19 and a beta of 1.39. The business's fifty day moving average is $546.03 and its 200-day moving average is $503.38.

Insider Activity at Intuitive Surgical

In related news, insider Jamie Samath sold 269 shares of the firm's stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now owns 8,757 shares of the company's stock, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,475 shares of company stock valued at $22,070,807. 0.90% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. State Street Corp boosted its position in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock worth $7,393,673,000 after purchasing an additional 210,363 shares during the period. FMR LLC lifted its position in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock worth $3,677,194,000 after acquiring an additional 143,440 shares during the period. Fisher Asset Management LLC raised its stake in Intuitive Surgical by 1.8% during the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. boosted its stake in Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after purchasing an additional 24,183 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.